United States · FDA National Drug Code directory
Etoposide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 16729-114_364ac37e-94f0-0dad-e063-6394a90aae33
- Product NDC
- 16729-114
- Form
- INJECTION
- Composition / generic term
- Etoposide
- Labeler
- Accord Healthcare Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150303
- Source listing expiry
- 20261231
Source-listed ingredients
- ETOPOSIDE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 BOX (16729-114-08) / 25 mL in 1 VIAL, MULTI-DOSE · 16729-114-08
- 1 VIAL, MULTI-DOSE in 1 BOX (16729-114-11) / 50 mL in 1 VIAL, MULTI-DOSE · 16729-114-11
- 1 VIAL, MULTI-DOSE in 1 BOX (16729-114-31) / 5 mL in 1 VIAL, MULTI-DOSE · 16729-114-31
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →